Skip to main content
SpringerLink
Log in
Book cover

Les biomarqueurs en médecine d’urgence pp 127–132Cite as

La myoglobine

  • Chapter

  • 654 Accesses

Part of the book series: Références en médecine d’urgence. Collection de la SFMU ((REFERMED))

Résumé

La myoglobine fut découverte en 1897 par Mörner [1] comme étant la substance responsable de la couleur rouge du muscle.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Mörner KHA (1897) Beobachtungen über den muskefarbstoff. Nord Med. Ark 30: 1–8

    Google Scholar 

  2. Flonta SE, Arena S, Pisacane A, et al. (2009) Expression and functional regulation of myoglobin in epithelial cancers. Am J Pathol 175: 201–206

    Article  PubMed  CAS  Google Scholar 

  3. Jeffreys AJ, Wilson V, Blanchetot A, et al. (1984) The human myoglobin gene: a third dispersed globin locus in the human genome. Nucleic Acids Res 12: 3235–3243

    Article  PubMed  CAS  Google Scholar 

  4. Hendgen-Cotta UB, Flögel U, Kelm M, Rassaf T (2010) Unmasking the Janus face of myoglobin in health and disease. J Exp Biol 213: 2734–2740

    Article  PubMed  CAS  Google Scholar 

  5. Flögel U, Fago A, Rassaf T (2010) Keeping the heart in balance: the fonctionnal interactions of myoglobin with nitrogen oxides. J Exp Biol 213: 2726–2733

    Article  PubMed  Google Scholar 

  6. De Waard H, Van’t Sant P (2009) Use of serum myoglobin assays for urine myoglobin measurements can cause false-negative results. Clin Chem 55: 1240–1241

    Article  PubMed  Google Scholar 

  7. Bonetti A, Monica C, Bonaguri C, et al. (2008) Interference by heterophilic antobodies in immunoassays: wrong increase of myoglobin values. Acta Biomed 79: 140–143

    PubMed  Google Scholar 

  8. Jurlander B, Clemmensen P, Wagner GS, Grande P (2000) Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by combined evaluation of a single serum value of cardiac troponin T, myoglobin, and creatine kinase MB mass. Eur Heart J 21: 382–389

    Article  PubMed  CAS  Google Scholar 

  9. Godet G, Bernard M, Ben Ayed S (2009) Marqueurs biologiques de l’infarctus du myocarde. Ann Fr Anesth Reanim 28: 321–331

    Article  PubMed  CAS  Google Scholar 

  10. Kurz K, Giannitsis E, Becker M, et al. (2011) Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT fot early identification of myocardial necrosis in the acute coronary syndrome. Clin Res Cardiol 100:209–215

    Article  PubMed  CAS  Google Scholar 

  11. Dekker MS, Mosterd A, Van’t Hof AWJ, Hoes AW (2010) Novel biochemical markers in suspected acute coronary syndrome: systematic review and critical appraisal. Heart 96: 1001–1010

    Article  PubMed  CAS  Google Scholar 

  12. Morrow DA, Cannon CP, Jesse RL, et al. (2007) National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes. Circulation 115: e356–375

    Article  PubMed  Google Scholar 

  13. Anderson JL, Adams CD, Antman EM, et al. (2007) ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non— ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 116: el48–e304

    Google Scholar 

  14. Pollack CV, Braunwald E (2007) Update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med 51: 591–606

    Article  PubMed  Google Scholar 

  15. HAS juillet 2010: Les marqueurs cardiaques dans la maladie coronaire et l’insuffisance cardiaque en médicine ambulatoire

    Google Scholar 

  16. De Lemos JA, Morrow DA, Gibson CM, et al. (2001) TIMI 14 investigators. Thrombosis in myocardial infarction: Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy. Am J Cardiol 88: 353–358

    Article  PubMed  Google Scholar 

  17. Lappalainen H, Tiula E, Uotila L, Mänttäri M (2002) Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: implications for follow-up. Crit Care Med 30: 2212–2215

    Article  PubMed  CAS  Google Scholar 

  18. Cervellin G, Comelli I, Lipi G (2010) Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med 48: 749–756

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de biochimie, Hôpital Bicêtre, 78, rue du Général-Leclerc, 94275, Le Kremlin-Bicêtre

    C. Cosson

Authors
  1. C. Cosson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Département de médecine d’urgence, Centre hospitalier Princesse Grace, 1, avenue Pasteur, BP 489, MC-98012, Monaco

    Yann-Érick Claessens

  2. Hôpital Tenon Service d’accueil des urgences, UPMC-Paris 6, 4, rue de la Chine, 75020, Paris, France

    Patrick Ray

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Cosson, C. (2012). La myoglobine. In: Claessens, YÉ., Ray, P. (eds) Les biomarqueurs en médecine d’urgence. Références en médecine d’urgence. Collection de la SFMU. Springer, Paris. https://doi.org/10.1007/978-2-8178-0297-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0297-8_17

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0296-1

  • Online ISBN: 978-2-8178-0297-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation